Last 12 months
Inside the activity.
0 purchase rows · 5 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 4 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 08, 2023 Filed Feb 10, 2023 23:12 UTC |
Miyata HatsukiEVP, Gen. Counsel & Secretary
|
GrantStock Option · Derivative | 2,600 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006045 · form4.xml · derivative · entry 2 Miyata Hatsuki · CIK 0001939613 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 2,600 shares Expires 2033-02-08 F3 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:12 UTC |
Miyata HatsukiEVP, Gen. Counsel & Secretary
|
GrantCommon Stock | 770 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006045 · form4.xml · nonDerivative · entry 1 Miyata Hatsuki · CIK 0001939613 · EVP, Gen. Counsel & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,837 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:11 UTC |
Boned FredericSVP/GM, Human Nutri. & Health
|
GrantStock Option · Derivative | 2,600 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006044 · form4.xml · derivative · entry 2 Boned Frederic · CIK 0001953220 · SVP/GM, Human Nutri. & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,600 Underlying: Common Stock · 2,600 shares Expires 2033-02-08 F3 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2: and 40% Year 3. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 23:11 UTC |
Boned FredericSVP/GM, Human Nutri. & Health
|
GrantCommon Stock | 770 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006044 · form4.xml · nonDerivative · entry 1 Boned Frederic · CIK 0001953220 · SVP/GM, Human Nutri. & Health 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,792 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F2 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
Wineinger Matthew DavidDirector
|
GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006029 · form4.xml · derivative · entry 2 Wineinger Matthew David · CIK 0001652942 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
Wineinger Matthew DavidDirector
|
GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006029 · form4.xml · nonDerivative · entry 1 Wineinger Matthew David · CIK 0001652942 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,955 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
Premdas Perry WDirector
|
GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006027 · form4.xml · derivative · entry 2 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
Premdas Perry WDirector
|
GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006027 · form4.xml · nonDerivative · entry 1 Premdas Perry W · CIK 0001311568 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,008 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
TELEVANTOS JOHN YDirector
|
GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006028 · form4.xml · derivative · entry 2 TELEVANTOS JOHN Y · CIK 0001236561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
TELEVANTOS JOHN YDirector
|
GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006028 · form4.xml · nonDerivative · entry 1 TELEVANTOS JOHN Y · CIK 0001236561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,336 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
Lee Joyce J.Director
|
GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006026 · form4.xml · derivative · entry 2 Lee Joyce J. · CIK 0001567830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
Lee Joyce J.Director
|
GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006026 · form4.xml · nonDerivative · entry 1 Lee Joyce J. · CIK 0001567830 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,236 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
Fish Kathleen BDirector
|
GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006024 · form4.xml · derivative · entry 2 Fish Kathleen B · CIK 0001598156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:20 UTC |
Fish Kathleen BDirector
|
GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006024 · form4.xml · nonDerivative · entry 1 Fish Kathleen B · CIK 0001598156 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,039 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:19 UTC |
Knutson Daniel EDirector
|
GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006025 · form4.xml · derivative · entry 2 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:19 UTC |
Knutson Daniel EDirector
|
GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006025 · form4.xml · nonDerivative · entry 1 Knutson Daniel E · CIK 0001730344 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,509 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:19 UTC |
Fischer David BDirector
|
GrantStock Option · Derivative | 1,790 | $0.00 Strike: $138.09 | $0.00 |
DisclosureSEC source: 0001140361-23-006023 · form4.xml · derivative · entry 2 Fischer David B · CIK 0001305182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,790 Underlying: Common Stock · 1,790 shares Expires 2033-02-08 F2 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3 Read SEC document |
| February 08, 2023 Filed Feb 10, 2023 22:19 UTC |
Fischer David BDirector
|
GrantCommon Stock | 530 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-23-006023 · form4.xml · nonDerivative · entry 1 Fischer David B · CIK 0001305182 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,269 F1 · shares: Ownership of restricted stock vests in Reporting Person 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. Read SEC document |
| September 15, 2022 Filed Sep 19, 2022 20:16 UTC |
Harris Theodore LDirector · Chairman, President & CEO
|
GrantStock Option (Right to Buy) · Derivative | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-033779 · form4.xml · derivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,000 Underlying: Common Stock · 130,000 shares Expires 2032-09-15 F1 · derivative.exercise_price: The stock options grant is structured in four tranches with increasing exercise prices as follows: (a) 25% at fair market value as of grant date of $125.71; (b) 25% at $125.71 plus 10% premium; (c) 25% at $125.71 plus 15% premium; and (d) 25% at $125.71 plus 20% premium. F2 · derivative.exercise_date: The stock options vest over a five-year period with: (a) 25% vesting on 9/15/2025; (b) 25% vesting on 9/15/2026; and (c) 50% vesting on 9/15/2027. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
SaleCommon Stock | 1,000 | $131.12 | $131,120.70 |
DisclosureSEC source: 0001140361-22-029845 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 F2 · price: This transaction was executed in multiple sales ranging from $131.00 to $131.51 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| August 12, 2022 Filed Aug 16, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
Exercise / conversionCommon Stock | 1,000 | $58.52 | $58,520.00 |
DisclosureSEC source: 0001140361-22-029845 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,430 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options Read SEC document |
| August 12, 2022 Filed Sep 20, 2022 20:15 UTC Amendment |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $58.52 | $0.00 |
DisclosureSEC source: 0001140361-22-034003 · form4.xml · derivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 1,000 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options that vested 20% on February 19, 2016, 40% on February 19, 2017, and 40% on February 19, 2018, and are exercisable. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
SaleCommon Stock | 2,629 | $127.01 | $333,903.77 |
DisclosureSEC source: 0001140361-22-028897 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 F2 · price: This transaction was executed in multiple sales ranging from $127.00 to $127.05 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| August 05, 2022 Filed Aug 9, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
Exercise / conversionCommon Stock | 2,629 | $50.32 | $132,291.28 |
DisclosureSEC source: 0001140361-22-028897 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options. Read SEC document |
| August 05, 2022 Filed Sep 20, 2022 20:15 UTC Amendment |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 2,629 | $0.00 Strike: $50.32 | $0.00 |
DisclosureSEC source: 0001140361-22-034002 · form4.xml · derivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,629 shares Expires 2024-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options that vested 20% on February 26, 2015, 40% on February 26, 2016, and 40% on February 26, 2017, and are exercisable. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
SaleCommon Stock | 1,371 | $127.00 | $174,120.56 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 6 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 F3 · price: This transaction was executed in multiple sales ranging from $127.0000 to $127.0150 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| August 04, 2022 Filed Aug 5, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
Exercise / conversionCommon Stock | 1,371 | $50.32 | $68,988.72 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 5 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options Read SEC document |
| August 04, 2022 Filed Sep 20, 2022 20:16 UTC Amendment |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,371 | $0.00 Strike: $50.32 | $0.00 |
DisclosureSEC source: 0001140361-22-034001 · form4.xml · derivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,629 Underlying: Common Stock · 1,371 shares Expires 2024-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Stock options that vested 20% on February 26, 2015, 40% on February 26, 2016, and 40% on February 26, 2017, and are exercisable. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
SaleCommon Stock | 1,401 | $125.02 | $175,148.12 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 4 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,430 F2 · price: This transaction was executed in multiple sales ranging from $125.0000 to $125.0550 per share, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer, or any security holder of the issuer full information regarding the number of shares and prices at which the transactions were affected regarding this footnote. Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
SaleCommon Stock | 2,200 | $126.00 | $277,206.38 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 3 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,831 Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
Exercise / conversionCommon Stock | 1,000 | $58.52 | $58,520.00 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options Read SEC document |
| August 03, 2022 Filed Aug 5, 2022 20:15 UTC |
van Gunsteren Job LeonardVice President
|
Exercise / conversionCommon Stock | 1,200 | $38.10 | $45,720.00 |
DisclosureSEC source: 0001140361-22-028360 · form4.xml · nonDerivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,031 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Exercise of fully vested non-qualified stock options Read SEC document |
| August 03, 2022 Filed Sep 20, 2022 20:16 UTC Amendment |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $58.52 | $0.00 |
DisclosureSEC source: 0001140361-22-034001 · form4.xml · derivative · entry 2 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 1,000 shares Expires 2025-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Stock options that vested 20% on February 19, 2016, 40% on February 19, 2017, and 40% on February 19, 2018, and are exercisable. Read SEC document |
| August 03, 2022 Filed Sep 20, 2022 20:16 UTC Amendment |
van Gunsteren Job LeonardSVP and GM, Specialty Products
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $38.10 | $0.00 |
DisclosureSEC source: 0001140361-22-034001 · form4.xml · derivative · entry 1 van Gunsteren Job Leonard · CIK 0001906287 · SVP and GM, Specialty Products 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,200 shares Expires 2023-02-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock options that vested 20% on February 19, 2014, 40% on February 19, 2015, and 40% on February 19, 2016, and are exercisable. Read SEC document |
| April 01, 2022 Filed Dec 30, 2022 21:15 UTC |
Backus William A.VP & Chief Accounting Officer
|
GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-047654 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · VP & Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,655 F1 · date: This is an inadvertent late filing due to an administrative error. F2 · shares: Ownership of restricted stock vests in Reporting Person in 3 years following the grant date, subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Issuer and the Reporting Person. F3 · balance_after: Includes acquisition of shares under the Balchem Corporation 401(k) plan. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 19:58 UTC |
Hyde James CSr. Vice President
|
Tax withholdingCommon Stock | 348 | $139.38 | $48,504.24 |
DisclosureSEC source: 0001140361-22-005746 · form4.xml · nonDerivative · entry 1 Hyde James C · CIK 0001842489 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,915 F1 · shares: 348 of the 930 Restricted Shares (date of grant 02/15/2018) that vested 02/15/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 19:55 UTC |
Stach Mark AGeneral Counsel
|
Tax withholdingCommon Stock | 302 | $139.38 | $42,092.76 |
DisclosureSEC source: 0001140361-22-005744 · form4.xml · nonDerivative · entry 1 Stach Mark A · CIK 0001731179 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,763 F1 · shares: 302 of the 840 Restricted Shares (date of grant 02/15/2018) that vested 02/15/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 19:49 UTC |
Backus William A.Chief Accounting Officer
|
Tax withholdingCommon Stock | 470 | $139.38 | $65,508.60 |
DisclosureSEC source: 0001140361-22-005742 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,786 F1 · shares: 470 of the 920 Restricted Shares (date of grant 02/15/2018) that vested 02/15/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 19:46 UTC |
Harris Theodore LDirector · CEO & President
|
Tax withholdingCommon Stock | 2,400 | $139.38 | $334,512.00 |
DisclosureSEC source: 0001140361-22-005739 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,558 F1 · shares: 2,400 of the 4,700 Restricted Shares (date of grant 02/15/2018) that vested 02/15/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 15, 2022 Filed Feb 16, 2022 19:42 UTC |
TELEVANTOS JOHN YDirector
|
Tax withholdingCommon Stock | 359 | $139.38 | $50,037.42 |
DisclosureSEC source: 0001140361-22-005737 · form4.xml · nonDerivative · entry 1 TELEVANTOS JOHN Y · CIK 0001236561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,806 F1 · shares: On February 15, 2018, the Company granted 845 restricted shares under the Company's Long-Term Incentive Program. The stock was subject to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement. 359 of the shares that vested February 15, 2022, were withheld to cover taxes. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:46 UTC |
Stach Mark AGeneral Counsel
|
Tax withholdingCommon Stock | 997 | $137.73 | $137,316.81 |
DisclosureSEC source: 0001140361-22-005592 · form4.xml · nonDerivative · entry 1 Stach Mark A · CIK 0001731179 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,065 F1 · shares: 997 of the 2,780 Restricted Shares (date of grant 02/13/2019) that vested 02/14/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:54 UTC |
Hyde James CSr. Vice President
|
Tax withholdingCommon Stock | 318 | $137.73 | $43,798.14 |
DisclosureSEC source: 0001140361-22-005594 · form4.xml · nonDerivative · entry 1 Hyde James C · CIK 0001842489 · Sr. Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,263 F1 · shares: 318 of the 850 Restricted Shares (date of grant 02/13/2019) that vested 02/14/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:43 UTC |
Bengtsson Carl MartinChief Financial Officer
|
Tax withholdingCommon Stock | 664 | $137.73 | $91,452.72 |
DisclosureSEC source: 0001140361-22-005588 · form4.xml · nonDerivative · entry 1 Bengtsson Carl Martin · CIK 0001766386 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,370 F1 · shares: 664 of the 1,300 Restricted Shares (date of grant 02/13/2019) that vested 02/14/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:33 UTC |
Harris Theodore LDirector · CEO & President
|
Tax withholdingCommon Stock | 3,130 | $137.73 | $431,094.90 |
DisclosureSEC source: 0001140361-22-005581 · form4.xml · nonDerivative · entry 1 Harris Theodore L · CIK 0001378228 · Director · CEO & President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,958 F1 · shares: 3,130 of the 6,130 Restricted Shares (date of grant 02/13/2019) that vested 02/14/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:45 UTC |
Backus William A.Chief Accounting Officer
|
Tax withholdingCommon Stock | 1,961 | $137.73 | $270,088.53 |
DisclosureSEC source: 0001140361-22-005591 · form4.xml · nonDerivative · entry 1 Backus William A. · CIK 0001530884 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,256 F1 · shares: 1,961 of the 3,840 Restricted Shares (date of grant 02/13/2019) that vested 02/14/2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 14, 2022 Filed Feb 15, 2022 21:42 UTC |
TELEVANTOS JOHN YDirector
|
Tax withholdingCommon Stock | 331 | $137.73 | $45,588.63 |
DisclosureSEC source: 0001140361-22-005587 · form4.xml · nonDerivative · entry 1 TELEVANTOS JOHN Y · CIK 0001236561 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,165 F1 · shares: On February 13, 2019, the Company granted 778 restricted shares under the Company's Long-Term Incentive Program. The stock was subject to restrictions on transfer until it vested in accordance with the provisions of the Restricted Stock Purchase Agreement. 331 of the shares that vested February 14, 2022 were withheld to cover taxes. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:15 UTC |
Stach Mark AGeneral Counsel
|
GrantStock Option · Derivative | 2,200 | $0.00 Strike: $138.07 | $0.00 |
DisclosureSEC source: 0001140361-22-005100 · form4.xml · derivative · entry 4 Stach Mark A · CIK 0001731179 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,500 Underlying: Common Stock · 2,200 shares Expires 2032-02-10 F4 · derivative.exercise_date: Options vest 20% Year 1; 40% Year 2; and 40% Year 3. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:15 UTC |
Stach Mark AGeneral Counsel
|
Tax withholdingCommon Stock | 829 | $138.07 | $114,460.03 |
DisclosureSEC source: 0001140361-22-005100 · form4.xml · nonDerivative · entry 3 Stach Mark A · CIK 0001731179 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,062 F3 · shares: 829 of the 2200 shares that vested February 10, 2022 were withheld to cover withholding taxes due upon vesting. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:15 UTC |
Stach Mark AGeneral Counsel
|
GrantCommon Stock | 2,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005100 · form4.xml · nonDerivative · entry 2 Stach Mark A · CIK 0001731179 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,891 F2 · shares: Acquired upon the settlement of performance shares granted on February 13, 2019, based upon a predetermined EBITDA performance target and total shareholder return against the Russell 2000 Index over a three-year period as a result of the satisfaction of those performance criteria. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 14:15 UTC |
Stach Mark AGeneral Counsel
|
GrantCommon Stock | 650 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-22-005100 · form4.xml · nonDerivative · entry 1 Stach Mark A · CIK 0001731179 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,691 F1 · shares: Ownership of the restricted stock does not vest in reporting person until three years from the grant date and is further subject to restrictions on transfer in accordance with the provisions of a Restricted Stock Grant Agreement between the Company and the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.